Mechanisms of nucleosome dynamics in vivo

Cold Spring Harbor Perspectives in Medicine

Volumn 6, Issue 9, 2016, Pages

  Henikoff, Steven ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION; CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME; DEVELOPMENT; DNA TRANSCRIPTION; GENE DISRUPTION; LANDSCAPE; MACHINE; NUCLEOSOME; CHROMATIN; DNA REPLICATION; GENETICS; METABOLISM;

DNA; HISTONE;

CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA; DNA REPLICATION; HISTONES; NUCLEOSOMES;

EID: 84986208768     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a026666     Document Type: Article

References (102)

1. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, Issaeva I, Canaani E, Salcini AE, Helin K. 2007. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449: 731-734.
2. Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, Pillus L, Reinberg D, Shi Y, Shiekhattar R, et al. 2007. New nomenclature for chromatin-modifying enzymes. Cell 131: 633-636.
3. Athwal RK, Walkiewicz MP, Baek S, Fu S, Bui M, Camps J, Ried T, Sung MH, Dalal Y. 2015. CENP-A nucleosomes localize to transcription factor hotspots and subtelomeric sites in human cancer cells. Epigenetics Chromatin 8: 2.
4. Bao Y, Konesky K, Park YJ, Rosu S, Dyer PN, Rangasamy D, Tremethick DJ, Laybourn PJ, Luger K. 2004. Nucleosomes containing the histone variant H2A. Bbd organize only 118 base pairs of DNA. EMBO J 23: 3314-3324.
5. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H, et al. 2013. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45: 1479-1482.
6. Bernt KM, Zhu N, Sinha AU, Vempati S, Faber J, Krivtsov AV, Feng Z, Punt N, Daigle A, Bullinger L, et al. 2011. MLLrearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 20: 66-78.
7. Bestor TH. 1996. DNA methyltransferases in mammalian development and genome defense. In Epigenetic mechanisms of gene regulation (ed. Russo VEA, Martienssen RA, Riggs AD), pp. 61-76. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
8. Canzio D, Chang EY, Shankar S, Kuchenbecker KM, Simon MD, Madhani HD, Narlikar GJ, Al-Sady B. 2011. Chromodomain-mediated oligomerization of HP1 suggests a nucleosome-bridging mechanism for heterochromatin assembly. Mol Cell 41: 67-81.
9. Carlson SM, Gozani O. 2016. Non-histone lysine methylation in the regulation of cancer pathways. Cold Spring Harb Perpect Med doi: 10.1101/cshperspect.a026435.
10. Carlson SM, Moore KE, Sankaran SM, Reynoird N, Elias JE, Gozani O. 2015. A proteomic strategy identifies lysine methylation of splicing factor snRNP70 by the SETMAR enzyme. J Biol Chem 290: 12040-12047.
11. Chaban Y, Ezeokonkwo C, Chung WH, Zhang F, Kornberg RD, Maier-Davis B, Lorch Y, Asturias FJ. 2008. Structure of a RSC-nucleosome complex and insights into chromatin remodeling. Nat Struct Mol Biol 15: 1272-1277.
12. Chakravarthy S, Gundimella SK, Caron C, Perche PY, Pehrson JR, Khochbin S, Luger K. 2005. Structural characterization of the histone variant macroH2A. Mol Cell Biol 25: 7616-7624.
13. Chang FT, Chan FL, JD RM, Udugama M, Mayne L, Collas P, Mann JR, Wong LH. 2015. CHK1-driven histone H3. 3 serine 31 phosphorylation is important for chromatin maintenance and cell survival in human ALT cancer cells. Nucleic Acids Res 43: 2603-2614.
14. Chen X, Cui D, Papusha A, Zhang X, Chu CD, Tang J, Chen K, Pan X, Ira G. 2012. The Fun30 nucleosome remodeller promotes resection of DNA double-strand break ends. Nature 489: 576-580.
15. Clapier CR, Cairns BR. 2009. The biology of chromatin remodeling complexes. Annu Rev Biochem 78: 273-304.
16. Colon-Bolea P, Crespo P. 2014. Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway. Bioessays 36: 1162-1169.
17. Copeland RA, Olhava EJ, Scott MP. 2010. Targeting epigenetic enzymes for drug discovery. Curr Opin Chem Biol 14: 505-510.
18. Costanzi C, Pehrson JR. 1998. Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393: 599-601.
19. Costelloe T, Louge R, Tomimatsu N, Mukherjee B, Martini E, Khadaroo B, Dubois K, Wiegant WW, Thierry A, Burma S, et al. 2012. The yeast Fun30 and human SMARCAD1 chromatin remodellers promote DNA end resection. Nature 489: 581-584.
20. Daigle SR, Olhava EJ, Therkelsen CA, Majer CR, Sneeringer CJ, Song J, Johnston LD, Scott MP, Smith JJ, Xiao Y, et al. 2011. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 20: 53-65.
21. Dion M, Kaplan T, Friedman N, Rando OJ. 2007. Dynamics of replication-independent histone turnover in budding yeast. Science 315: 1405-1408.
22. Downey M, Baetz K. 2015. Building a KATalogue of acetyllysine targeting and function. Brief Funct Genomics 15: 109-118.
23. Drane P, Ouararhni K, Depaux A, Shuaib M, Hamiche A. 2010. The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3. 3. Genes Dev 24: 1253-1265.
24. Eastlund A, Malik SS, Fischer CJ. 2013. Kinetic mechanism of DNA translocation by the RSC molecular motor. Arch Biochem Biophys 532: 73-83.
25. Elsasser SJ, Huang H, Lewis PW, Chin JW, Allis CD, Patel DJ. 2012. DAXXenvelops a histone H3. 3-H4 dimer for H3. 3-specific recognition. Nature 491: 560-565.
26. Eustermann S, Yang JC, Law MJ, Amos R, Chapman LM, Jelinska C, Garrick D, Clynes D, Gibbons RJ, Rhodes D, et al. 2011. Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin. Nat Struct Mol Biol 18: 777-782.
27. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, et al. 2010. Selective inhibition of BET bromodomains. Nature 468: 1067-1073.
28. Flynn RL, Cox KE, Jeitany M, Wakimoto H, Bryll AR, Ganem NJ, Bersani F, Pineda JR, Suva ML, Benes CH, et al. 2015. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. Science 347: 273-277.
29. Funato K, Major T, Lewis PW, Allis CD, Tabar V. 2014. Use of human embryonic stem cells to model pediatric gliomas with H3. 3K27M histone mutation. Science 346: 1529-1533.
30. Ganguli D, Chereji RV, Iben JR, Cole HA, Clark DJ. 2014. RSC-dependent constructive and destructive interference between opposing arrays of phased nucleosomes in yeast. Genome Res 24: 1637-1649.
31. Gaydos LJ, Wang W, Strome S. 2014. Gene repression. H3K27me and PRC2 transmit a memory of repression across generations and during development. Science 345: 1515-1518.
32. Grau DJ, Chapman BA, Garlick JD, Borowsky M, Francis NJ, Kingston RE. 2011. Compaction of chromatin by diverse Polycomb group proteins requires localized regions of high charge. Genes Dev 25: 2210-2221.
33. Hargreaves DC, Crabtree GR. 2011. ATP-dependent chromatin remodeling: Genetics, genomics and mechanisms. Cell Res 21: 396-420.
34. Hartley PD, Madhani HD. 2009. Mechanisms that specify promoter nucleosome location and identity. Cell 137: 445-458.
35. Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, et al. 2011a. Altered telomeres in tumors with ATRX and DAXX mutations. Science 333: 425.
36. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, et al. 2011b. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 179: 1608-1615.
37. Henikoff S, Shilatifard A. 2011. Histone modification: Cause or cog? Trends Genet 27: 389-396.
38. Henikoff S, Smith MM. 2015. Histone variants and epigenetics. Cold Spring Harb Perspect Biol 7: a019364.
39. Herz HM, Morgan M, Gao X, Jackson J, Rickels R, Swanson SK, Florens L, Washburn MP, Eissenberg JC, Shilatifard A. 2014. Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling. Science 345: 1065-1070.
40. Hinz JM, Czaja W. 2015. Facilitation of base excision repair by chromatin remodeling. DNA Repair (Amst) 36: 91-97.
41. Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA, Shah PK, Liu J, Khramtsov A, Tretiakova MS, et al. 2008. Genomic analysis of estrogen cascade reveals histone variant H2A. Z associated with breast cancer progression. Mol Syst Biol 4: 188.
42. Jiao L, Liu X. 2015. Structural basis of histone H3K27 trimethylation by an active Polycomb repressive complex 2. Science 350: aac4383.
43. Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, Schulick RD, Tang LH, Wolfgang CL, Choti MA, et al. 2011. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331: 1199-1203.
44. Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, Crabtree GR. 2013. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 45: 592-601.
45. Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, Menendez S, Vardabasso C, Leroy G, Vidal CI, et al. 2010. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 468: 1105-1109.
46. Kim KH, Roberts CW. 2014. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth. Cancer Genet 207: 365-372.
47. Kingston RE, Tamkun J. 2014. Transcriptional regulation by trithorax-group proteins. Cold Spring Harb Perspect Biol 6: 019349.
48. Koppens M, van Lohuizen M. 2015. Context-dependent actions of Polycomb repressors in cancer. Oncogene 17: 1341-1352.
49. Lacoste N, Woolfe A, Tachiwana H, Garea AV, Barth T, Cantaloube S, Kurumizaka H, Imhof A, Almouzni G. 2014. Mislocalization of the centromeric histone variant CenH3/CENP-A in human cells depends on the chaperone DAXX. Mol Cell 53: 631-644.
50. Lai F, Shiekhattar R. 2014. Enhancer RNAs: The new molecules of transcription. Curr Opin Genet Dev 25: 38-42.
51. Laufer BI, Singh SM. 2015. Strategies for precision modulation of gene expression by epigenome editing: An overview. Epigenetics Chromatin 8: 34.
52. Law MJ, Lower KM, Voon HP, Hughes JR, Garrick D, Viprakasit V, Mitson M, De Gobbi M, Marra M, Morris A, et al. 2010. ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a sizedependent manner. Cell 143: 367-378.
53. Lee HG, Kahn TG, Simcox A, Schwartz YB, Pirrotta V. 2015. Genome-wide activities of polycomb complexes control pervasive transcription. Genome Res 25: 1170-1181.
54. Levy D, Liu CL, Yang Z, Newman AM, Alizadeh AA, Utz PJ, Gozani O. 2011. A proteomic approach for the identification of novel lysine methyltransferase substrates. Epigenetics Chromatin 4: 19.
55. Lewis EB. 1978. A gene complex controlling segmentation in Drosophila. Nature 276: 565-570.
56. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD. 2010. Daxx is an H3. 3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci 107: 14075-14080.
57. Lewis PW, Muller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, Garcia BA, Muir TW, Becher OJ, Allis CD. 2013. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340: 857-861.
58. Li S. 2015. Transcription coupled nucleotide excision repair in the yeast Saccharomyces cerevisiae: The ambiguous role of Rad26. DNA Repair (Amst) 36: 43-48.
59. Liu Z, Lavis LD, Betzig E. 2015. Imaging live-cell dynamics and structure at the single-molecule level. Mol Cell 58: 644-659.
60. Lorch Y, Maier-Davis B, Kornberg RD. 2006. Chromatin remodeling by nucleosome disassembly in vitro. Proc Natl Acad Sci 103: 3090-3093.
61. Lorch Y, Maier-Davis B, Kornberg RD. 2010. Mechanism of chromatin remodeling. Proc Natl Acad Sci 107: 3458-3462.
62. Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JH, Sung PA, Jasin M, et al. 2012. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 8: e1002772.
63. Lu C, Jain SU, Hoelper D, Bechet D, Molden RC, Ran L, Murphy D, Venneti S, Hameed M, Pawel BR, et al. 2016. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science 352: 844-849.
64. Ma N, Luo Y, Wang Y, Liao C, Ye WC, Jiang S. 2016. Selective histone deacetylase inhibitors with anticancer activity. Curr Top Med Chem 16: 415-426.
65. Marzluff WF, Gongidi P, Woods KR, Jin J, Maltais LJ. 2002. The human and mouse replication-dependent histone genes. Genomics 80: 487-498.
66. McBrian MA, Behbahan IS, Ferrari R, Su T, Huang TW, Li K, Hong CS, Christofk HR, Vogelauer M, Seligson DB, et al. 2013. Histone acetylation regulates intracellular pH. Mol Cell 49: 310-321.
67. Morishita M, Mevius D, di Luccio E. 2014. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L. BMC Struct Biol 14: 25.
68. Picketts DJ, Higgs DR, Bachoo S, Blake DJ, Quarrell OW, Gibbons RJ. 1996. ATRX encodes a novel member of the SNF2 family of proteins: Mutations point to a common mechanism underlying the ATR-X syndrome. Hum Mol Genet 5: 1899-1907.
69. Pon JR, Marra MA. 2015. Driver and passenger mutations in cancer. Annu Rev Pathol 10: 25-50.
70. Popovic R, Martinez-Garcia E, Giannopoulou EG, Zhang Q, Zhang Q, Ezponda T, Shah MY, Zheng Y, Will CM, Small EC, et al. 2014. Histone methyltransferase MMSET/ NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet 10: e1004566.
71. Ptashne M. 2007. On the use of the word “epigenetic. ” Curr Biol 17: R233-R236.
72. Quenet D, Dalal Y. 2012. The CENP-A nucleosome: A dynamic structure and role at the centromere. Chromosome Res 20: 465-479.
73. Ramachandran S, Henikoff S. 2015. Replicating nucleosomes. Sci Adv 1: e1500587.
74. Ramachandran S, Zentner GE, Henikoff S. 2015. Asymmetric nucleosomes flank promoters in the budding yeast genome. Genome Res 25: 381-390.
75. Ratnakumar K, Duarte LF, LeRoy G, Hasson D, Smeets D, Vardabasso C, Bonisch C, Zeng T, Xiang B, Zhang DY, et al. 2012. ATRX-mediated chromatin association of histone variant macroH2A1 regulates a-globin expression. Genes Dev 26: 433-438.
76. Ray-Gallet D, Quivy J-P, Scamps C, Martini EM, Lipinski M, Almouzni G. 2002. HIRA is critical for a nucleosome assembly pathway independent of DNA synthesis. Mol Cell 9: 1091-1100.
77. Riedel SS, Neff T, Bernt KM. 2015. Histone profiles in cancer. Pharmacol Ther 154: 87-109.
78. Schneiderman JI, Sakai A, Goldstein S, Ahmad K. 2009. The XNP remodeler targets dynamic chromatin in Drosophila. Proc Natl Acad Sci 106: 14472-14477.
79. Schneiderman JI, Orsi GA, Hughes KT, Loppin B, Ahmad K. 2012. Nucleosome-depleted chromatin gaps recruit assembly factors for the H3. 3 histone variant. Proc Natl Acad Sci 109: 19721-19726.
80. Schotta G, Ebert A, Krauss V, Fischer A, Hoffmann J, Rea S, Jenuwein T, Dorn R, Reuter G. 2002. Central role of Drosophila SU(VAR)3-9 in histone H3-K9 methylation and heterochromatic gene silencing. EMBO J 21: 1121-1131.
81. Schwartz YB, Pirrotta V. 2013. A new world of polycombs: Unexpected partnerships and emerging functions. Nat Rev Genet 14: 853-864.
82. Shi J, Vakoc CR. 2014. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol Cell 54: 728-736.
83. Sporn JC, Jung B. 2012. Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer. Am J Pathol 180: 2516-2526.
84. Steffen PA, Ringrose L. 2014. What are memories made of? How polycomb and trithorax proteins mediate epigenetic memory. Nat Rev Mol Cell Biol 15: 340-356.
85. Suto RK, Clarkson MJ, Tremethick DJ, Luger K. 2000. Crystal structure of a nucleosome core particle containing the variant histone H2A. Z. Nat Struct Biol 7: 1121-1124.
86. Tamkun JW, Deuring R, Scott MP, Kissinger M, Pattatucci AM, Kaufman TC, Kennison JA. 1992. brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 68: 561-572.
87. Teves SS, Weber CM, Henikoff S. 2014. Transcribing through the nucleosome. Trends Biochem Sci 39: 577-586.
88. Valdes-Mora F, Song JZ, Statham AL, Strbenac D, Robinson MD, Nair SS, Patterson KI, Tremethick DJ, Stirzaker C, Clark SJ. 2012. Acetylation of H2A. Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer. Genome Res 22: 307-321.
89. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. 2013. Cancer genome landscapes. Science 339: 1546-1558.
90. Watanabe S, Peterson CL. 2010. The INO80 family of chromatin-remodeling enzymes: Regulators of histone variant dynamics. Cold Spring Harb Symp Quant Biol 75: 35-42.
91. Watanabe S, Radman-Livaja M, Rando OJ, Peterson CL. 2013. A histone acetylation switch regulates H2A. Z deposition by the SWR-C remodeling enzyme. Science 340: 195-199.
92. Waterborg JH. 1993. Histone synthesis and turnover in alfalfa. Fast loss of highly acetylated replacement histone variant H3. 2. J Biol Chem 268: 4912-4917.
93. Waterborg JH. 2002. Dynamics of histone acetylation in vivo. A function for acetylation turnover? Biochem Cell Biol 80: 363-378.
94. Waters R, van Eijk P, Reed S. 2015. Histone modification and chromatin remodeling during NER. DNA Repair (Amst) 36: 105-113.
95. Weintraub H, Groudine M. 1976. Chromosomal subunits in active genes have an altered conformation. Science 193: 848-856.
96. Wen H, Li Y, Xi Y, Jiang S, Stratton S, Peng D, Tanaka K, Ren Y, Xia Z, Wu J, et al. 2014. ZMYND11 links histone H3. 3K36me3 to transcription elongation and tumour suppression. Nature 508: 263-268.
97. Wilson BG, Roberts CW. 2011. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11: 481-492.
98. Wolffe AP. 1992. Chromatin: Structure and function. Academic, San Diego.
99. Wollmann P, Cui S, Viswanathan R, Berninghausen O, Wells MN, Moldt M, Witte G, Butryn A, Wendler P, Beckmann R, et al. 2011. Structure and mechanism of the Swi2/Snf2 remodeller Mot1 in complex with its substrate TBP. Nature 475: 403-407.
100. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, et al. 2012. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44: 251-253.
101. Yang F, Kemp CJ, Henikoff S. 2015. Anthracyclines induce double-strandDNAbreaks at active gene promoters. Mutat Res 773: 9-15.
102. Zentner GE, Henikoff S. 2013. Mot1 redistributes TBP from TATA-containing to TATA-less promoters. Mol Cell Biol 33: 4996-5004.